Immix Biopharma Balance Sheet Health
Financial Health criteria checks 6/6
Immix Biopharma has a total shareholder equity of $27.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $34.3M and $6.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$29.32m |
Equity | US$27.63m |
Total liabilities | US$6.72m |
Total assets | US$34.35m |
Recent financial health updates
Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?
Aug 12Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?
Nov 28Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth?
Jul 12We're Not Very Worried About Immix Biopharma's (NASDAQ:IMMX) Cash Burn Rate
Mar 29Immix Biopharma (NASDAQ:IMMX) Is In A Good Position To Deliver On Growth Plans
Sep 13We're Hopeful That Immix Biopharma (NASDAQ:IMMX) Will Use Its Cash Wisely
May 21Recent updates
Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?
Aug 12Will Immix Biopharma (NASDAQ:IMMX) Spend Its Cash Wisely?
Nov 28Is Immix Biopharma (NASDAQ:IMMX) In A Good Position To Invest In Growth?
Jul 12We're Not Very Worried About Immix Biopharma's (NASDAQ:IMMX) Cash Burn Rate
Mar 29Immix Biopharma (NASDAQ:IMMX) Is In A Good Position To Deliver On Growth Plans
Sep 13We're Hopeful That Immix Biopharma (NASDAQ:IMMX) Will Use Its Cash Wisely
May 21Financial Position Analysis
Short Term Liabilities: IMMX's short term assets ($32.9M) exceed its short term liabilities ($5.7M).
Long Term Liabilities: IMMX's short term assets ($32.9M) exceed its long term liabilities ($1.1M).
Debt to Equity History and Analysis
Debt Level: IMMX is debt free.
Reducing Debt: IMMX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IMMX has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: IMMX has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 71.4% each year.